Abstract

Moelis & Company is scheduled to release its quarterly results on April 29, 2026 Post Market, and consensus points to year-over-year revenue growth with mixed profitability trends, while recent institutional commentary skews cautious heading into the print.

Market Forecast

Based on current-quarter forecasts, revenue is estimated at 337.80 million US dollars, up 12.87% year over year, with estimated EBIT at 56.22 million US dollars, up 42.80% year over year, and adjusted EPS at 0.55, down 1.19% year over year; margin forecasts were not available. Highlights for the company’s core advisory activities center on the anticipated conversion of mandates into fees, while the near-term outlook emphasizes disciplined cost control to support earnings quality. The most promising contribution in the model is operating leverage reflected in EBIT growth outpacing revenue growth, signaling improved fee realization and utilization if volumes arrive in line with expectations.

Last Quarter Review

In the previous quarter, Moelis & Company reported revenue of 487.94 million US dollars (up 11.22% year over year), a gross profit margin of 93.68%, GAAP net profit attributable to the parent company of 87.87 million US dollars, a net profit margin of 18.01%, and adjusted EPS of 1.13 (down 4.24% year over year). Financially, EBIT was 129.69 million US dollars, a 1.92% year-over-year decline, yet both revenue and earnings surpassed prior estimates, underscoring healthy fee conversion and expense control into the close of the period. Segment details were not available in the collected dataset; at the company level, revenue advanced 11.22% year over year to 487.94 million US dollars, highlighting broadly resilient advisory activity across the franchise during the quarter.

Current Quarter Outlook

Main business: Advisory fee revenue trajectory into April 29

The forecast framework implies a revenue print of 337.80 million US dollars, or 12.87% growth year over year, pointing to sustained fee realization from mandates that have reached billing milestones. As an advisory-led model, quarterly results are intrinsically linked to the timing and size of individual transaction closings; the dispersion of deal completions in any given quarter can materially impact both the top line and the compensation ratio. With adjusted EPS projected at 0.55, down 1.19% year over year, the key watch items are the level of realized fees relative to announced pipelines and the cadence of closings through quarter end. Cost discipline remains a pivotal supporting factor: a higher gross margin base offers cushion, but earnings quality will be heavily determined by the compensation and benefits line, as well as non-compensation overheads as activity scales. A print that aligns with or exceeds the 337.80 million US dollars revenue estimate should provide the operating base for EPS to land close to the 0.55 forecast, provided the compensation ratio does not drift materially above historical ranges.

Most promising contribution: Operating leverage to EBIT

The most pronounced modeled improvement is at the EBIT line, with a 42.80% year-over-year increase to 56.22 million US dollars implied despite revenue growth of 12.87%. This gap suggests anticipated operating leverage stemming from the mix of higher-fee transactions and stronger utilization of senior and mid-level bankers, which can accelerate EBIT faster than revenues when compensation costs scale at a slower clip. Any upside surprise in revenue mix—such as a higher proportion of complex transactions with premium fees—could widen the incremental margin and lift EBIT above forecasts. Conversely, if closings skew toward lower-fee work or if the firm elected to invest ahead of revenue (for example, adding headcount or absorbing higher travel and marketing spend to support origination), realized leverage could compress, bringing EBIT closer to a linear relationship with revenue. The balance of these factors this quarter will likely be a prime determinant of how investors interpret the sustainability of earnings power into the second half.

Key stock price drivers this quarter

Share performance around the release will be driven by the revenue versus 337.80 million US dollars benchmark, the adjusted EPS print relative to the 0.55 estimate, and management’s qualitative commentary on the near-term fee pipeline conversion. Investors will be sensitive to any indications on compensation ratios and expense run-rates, as even modest deviations can impact EPS given the advisory model’s cost structure. The cadence of announced-to-closed transactions through quarter end—and whether those closings carry above-average fee yields—will be closely parsed. Dividend continuity and capital return remain relevant for total return framing, yet the immediate reaction will focus on the earnings bridge: revenue realization, compensation discipline, and non-compensation costs. Any color on backlog quality and the breadth of mandates should help calibrate whether the modeled EBIT leverage is a one-off effect or has legs into subsequent quarters.

Analyst Opinions

Across recent commentary captured between January 1, 2026 and April 22, 2026, the balance of opinion leans bearish. On February 5, 2026, Morgan Stanley lifted its price target to 90 US dollars and maintained an Overweight rating, marking a supportive outlier on the positive side. In contrast, multiple institutions have turned more cautious: on March 12, 2026, UBS reduced its price target to 59 US dollars and maintained a Neutral rating while noting the average rating across the coverage universe remained Hold; on April 8, 2026, UBS further adjusted expectations, reiterating a Neutral stance with commentary that the consensus remained centered around Hold and implying limited near-term upside; and on April 10, 2026, BofA Securities adjusted its target to 75 US dollars while highlighting a Hold consensus and a mean price target near the low 70s. Counting up these views yields a ratio of bearish-to-bullish at roughly 3:1 in the latest window, with cautious or neutral tones dominating.

The majority view emphasizes a prudent stance into the April 29, 2026 release. UBS’s sequential target reductions underscore a guarded outlook that places emphasis on valuation balance against near-term earnings visibility, effectively arguing that while core advisory momentum is present, upside may be constrained unless revenue realization decisively outpaces expectations. BofA’s target adjustment is consistent with this framework, reflecting a tempered stance that looks for confirmation in revenue conversion and margin steadiness before recalibrating targets higher. These perspectives concentrate on two critical near-term variables: the translation of mandates into realized fees and the compensation ratio’s path as activity scales. If Moelis & Company reports revenues at or above the 337.80 million US dollars mark and delivers adjusted EPS around or better than 0.55, while keeping compensation and non-compensation costs aligned with historical guardrails, the bearish tilt could be challenged; however, the predominant institutional message is to wait for that confirmation.

From a practical angle, the consensus Hold posture also ties back to the dispersion in target prices observed in recent notes—from the high-50s to around 90 US dollars—highlighting divergent views on how quickly activity could normalize and how much operating leverage can be captured. The bearish majority anticipates that, in the short run, revenue and EPS outcomes may track close to forecasts rather than meaningfully surpass them, which limits scope for multiple expansion without compelling upside surprises or stronger pipeline commentary. Taken together, the institutional stance heading into April 29, 2026 is cautious: expectations for revenue and EBIT growth are present in forecasts, yet the burden of proof is on realized fees and disciplined compensation to translate that top-line into an earnings path that can shift the rating mix from Hold toward Buy.